You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ICP

Showing 1 - 25 of 706
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ICP Threshold After Decompressive Craniectomy

Not yet recruiting
  • Traumatic Brain Injury
    • (no location specified)
    Oct 9, 2023

    Hematological Malignancies Trial in Tianjin (ICP-248)

    Not yet recruiting
    • Hematological Malignancies
    • Tianjin, Tianjin, China
      Hematology Hospital, Chinese Academy of Medical Sciences
    Feb 13, 2023

    Healthy Volunteers Trial in Daytona Beach (iCP-NI, Placebo)

    Recruiting
    • Healthy Volunteers
    • Daytona Beach, Florida
      Labcorp Clinical Research Unit Inc.
    Feb 21, 2023

    Patients With Advanced Solid Tumors Trial in Sichuan (ICP-033 tablet)

    Recruiting
    • Patients With Advanced Solid Tumors
    • ICP-033 tablet
    • Sichuan, Chengdu, China
      West China Hospital of Sichuan University
    Nov 28, 2022

    Increased Intracranial Pressure Trial (doppler study of central retinal artery)

    Not yet recruiting
    • Increased Intracranial Pressure
    • doppler study of central retinal artery
    • (no location specified)
    Jun 6, 2023

    Advanced Solid Tumors Harboring NTRK Fusion, Primary CNS Tumors Harboring NTRK Fusion Trial in Guangzhou (ICP-723)

    Recruiting
    • Advanced Solid Tumors Harboring NTRK Fusion
    • Primary Central Nervous System Tumors Harboring NTRK Fusion
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Feb 16, 2023

    Systemic Lupus Erythematosus Trial in China (ICP-022, Placebos)

    Completed
    • Systemic Lupus Erythematosus
    • Bengbu, Anhui, China
    • +10 more
    Nov 28, 2022

    Advanced Solid Tumors Trial in Kansas City (ICP-723)

    Recruiting
    • Advanced Solid Tumors
    • Kansas City, Kansas
      University of Kansas Medical / Cancer Centers
    Sep 8, 2022

    Relapsed and/or Refractory Multiple Myeloma Trial in China (ICP-490)

    Not yet recruiting
    • Relapsed and/or Refractory Multiple Myeloma
    • Beijing, Beijing, China
    • +4 more
    Jan 30, 2023

    Hydrocephalus Trial (FlowSense)

    Not yet recruiting
    • Hydrocephalus
    • FlowSense
    • (no location specified)
    Sep 15, 2022

    Patients With Advanced Solid Tumors Trial in Shanghai (ICP-189)

    Not yet recruiting
    • Patients With Advanced Solid Tumors
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    May 8, 2022

    Solid Tumor Trial in Shanghai (ICP-105)

    Completed
    • Solid Tumor
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Jul 5, 2022

    Healthy Subjects Trial in Jinan (ICP-332, Placebo)

    Completed
    • Healthy Subjects
    • Jinan, China
      Jinan Central Hospital
    Aug 5, 2022

    Psoriasis Trial in Nanjing (ICP-488, Placebo)

    Recruiting
    • Psoriasis
    • Nanjing, Jiangsu, China
      Hospital for Skin Diseases, Institute of Dermatology, Chinese Ac
    Aug 5, 2022

    Intracranial Pressure Increase Trial in Valencia (Posterior fossa intracranial pressure measurement)

    Recruiting
    • Intracranial Pressure Increase
    • Posterior fossa intracranial pressure measurement
    • Valencia, Spain
    • +1 more
    May 23, 2022

    Moderate to Severe Plaque Psoriasis Trial in China (ICP-488 Tablets, ICP-488 Placebo)

    Not yet recruiting
    • Moderate to Severe Plaque Psoriasis
    • ICP-488 Tablets
    • ICP-488 Placebo
    • Bengbu, Anhui, China
    • +31 more
    Oct 26, 2023

    Low Dose Ketamine Infusion in Septic Patient on Non-invasive

    Recruiting
    • Intracranial Pressure Changes
      • Zagazig, Egypt
        Zagazig university
      Jul 22, 2022

      Moderate to Severe Atopic Dermatitis Trial in China (ICP-332, ICP-332 Placebo)

      Not yet recruiting
      • Moderate to Severe Atopic Dermatitis
      • Beijing, Beijing, China
      • +21 more
      Jan 18, 2023

      Bile Acids Metabolism and Genetic Mutation Profile in ICP in

      Recruiting
      • Intrahepatic Cholestasis of Pregnancy
      • +2 more
        • Chandigarh, India
          Dr. Madhumita Premkumar
        Jan 17, 2023

        Subarachnoid Hemorrhage, Stroke, Stroke, Ischemic Trial in São Paulo (ICP wave morphology comparison between a non-invasive

        Completed
        • Subarachnoid Hemorrhage
        • +4 more
        • ICP wave morphology comparison between a non-invasive (Brain4care) and a invasive method
        • São Paulo, Brazil
          Federal University of São Paulo
        Nov 3, 2021

        Solid Tumors Trial in Guangdong, Hangzhou (ICP-723)

        Recruiting
        • Solid Tumors
        • Guangdong, Guangzhou, China
        • +1 more
        Oct 20, 2021

        CNS Lymphoma Trial in Shanghai (Orelabrutinib, Rituximab, Chemotherapy)

        Not yet recruiting
        • CNS Lymphoma
        • Shanghai, Shanghai, China
          Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
        Jun 22, 2023

        Advanced Solid Tumors, Urothelial Carcinoma, Cholangiocarcinoma Trial in Australia, United States (Drug ICP-192)

        Recruiting
        • Advanced Solid Tumors
        • +2 more
        • Drug ICP-192
        • Tucson, Arizona
        • +8 more
        Jan 28, 2022

        The Microbiome Composition in Recurring Intrahepatic Cholestasis

        Completed
        • Intrahepatic Cholestasis of Pregnancy
        • Exploratory
        • Lund, Sweden
        • +1 more
        Nov 26, 2021

        Severe Traumatic Brain Injury, Intracranial Hypertension Trial in Fort Sam Houston, San Antonio (External Lumbar drainage)

        Not yet recruiting
        • Severe Traumatic Brain Injury
        • Intracranial Hypertension
        • External Lumbar drainage
        • Fort Sam Houston, Texas
        • +1 more
        Jun 3, 2023